Resultados de procura - Rafe Shellooe

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor

    Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor por Chao Zhang, Prabha N. Ibrahim, Jiazhong Zhang, Elizabeth A. Burton, Gaston Habets, Ying Zhang, Ben Powell, Brian L. West, Bernice Matusow, Garson Tsang, Rafe Shellooe, Heidi Carias, Hoa Nguyen, Adhirai Marimuthu, Kam Y. J. Zhang, Angela J. Oh, Ryan Bremer, Clarence R. Hurt, Dean R. Artis, Guoxian Wu, Marika Nespi, Wayne Spevak, Paul Lin, K. B. Nolop, Peter Hirth, Greg H. Tesch, Gideon Bollag

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397

    Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397 por Catherine C. Smith, Chao Zhang, Kimberly C. Lin, Elisabeth A. Lasater, Ying Zhang, Evan Massi, Lauren E. Damon, Matthew Pendleton, Ali Bashir, Robert Sebra, Alexander E. Perl, Andrew Kasarskis, Rafe Shellooe, Garson Tsang, Heidi Carias, Ben Powell, Elizabeth A. Burton, Bernice Matusow, Jiazhong Zhang, Wayne Spevak, Prabha N. Ibrahim, Mai H. Le, Henry H. Hsu, Gaston Habets, Brian L. West, Gideon Bollag, Neil P. Shah

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

    Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity por James Tsai, John Tayu Lee, Weiru Wang, Jiazhong Zhang, Hanna Cho, Shumeye Mamo, Ryan Bremer, S. Gillette, Jun Kong, Nikolas K. Haass, Katrin Sproesser, Ling Li, Keiran S.M. Smalley, Daniel W. Fong, Yongliang Zhu, Adhirai Marimuthu, Hoa Nguyen, Billy Lam, Jennifer Liu, Ivana Cheung, Julie Rice, Yoshihisa Suzuki, Catherine A. Luu, Calvin Settachatgul, Rafe Shellooe, John Cantwell, Sung‐Hou Kim, Joseph Schlessinger, Kam Y. J. Zhang, Brian L. West, Ben Powell, Gaston Habets, Chao Zhang, Prabha N. Ibrahim, Peter Hirth, Dean R. Artis, Meenhard Herlyn, Gideon Bollag

    Publicado 2008
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

    Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma por Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim, Hanna Cho, Wayne Spevak, Chao Zhang, Ying Zhang, Gaston Habets, Elizabeth A. Burton, Bernice H. Wong, Garson Tsang, Brian L. West, Ben Powell, Rafe Shellooe, Adhirai Marimuthu, Hoa Nguyen, Kam Y. J. Zhang, Dean R. Artis, Joseph Schlessinger, Fei Su, Brian Higgins, Raman Iyer, Kurt D’Andrea, Astrid Koehler, Michael Stumm, Paul Lin, Richard J. Lee, Joseph F. Grippo, Igor Puzanov, Kevin B. Kim, Antoni Ribas, Grant A. McArthur, Jeffrey A. Sosman, Paul B. Chapman, Keith T. Flaherty, Xiaowei Xu, Katherine L. Nathanson, K. B. Nolop

    Publicado 2010
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

    BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor por Hatice Gülçin Özer, Dalia El‐Gamal, Ben Powell, Zachary A. Hing, James S. Blachly, Bonnie K. Harrington, Shaneice Mitchell, Nicole R. Grieselhuber, Katie Williams, Tzung-Huei Lai, Lapo Alinari, Robert A. Baiocchi, Lindsey T. Brinton, Elizabeth Baskin, Matthew Cannon, Larry Beaver, Virginia M. Goettl, David Lucas, Jennifer A. Woyach, Deepa Sampath, Amy M. Lehman, Lianbo Yu, Jiazhong Zhang, Yan Ma, Ying Zhang, Wayne Spevak, Songyuan Shi, Paul Severson, Rafe Shellooe, Heidi Carias, Garson Tsang, Ken C. Dong, Todd Ewing, Adhirai Marimuthu, Christina Tantoy, Jason Walters, Laura Sanftner, Hamid Rezaei, Marika Nespi, Bernice Matusow, Gaston Habets, Prabha N. Ibrahim, Chao Zhang, Ewy A. Mathé, Gideon Bollag, John C. Byrd, Rosa Lapalombella

    Publicado 2018
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

    Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor por William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary C. Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: